Asia Pacific Dermal Fillers Treatment Market is estimated to witness a rise in revenue from US$ 810.3 Million in 2021 to US$ 1,650.3 Million by 2030. The market is registering a CAGR of 8.9% during the forecast period 2022-2030. In terms of volume, the market is expected to grow at a CAGR of 8.0% over the forecast period. 

According to State Administration for Market Regulations (SAMR), in 2020, China established 5,510 new medical beauty institutions, accounting a share of 17% of the global market. Moreover, women in China annually spend around 20 billion yuan (US$2.42 billion) to change their looks and enhance their aesthetic beauty.

Dermal fillers contain substances such as hyaluronic acid or collagen, which are found naturally in skin’s connective tissue and are injected into wrinkles to minimize their appearance. Their effect is physical rather than pharmacological, metabolic, or immunological. The substances, which are also found in natural connective tissue, bind water, thereby giving the skin more volume and smoothing wrinkles. The body degrades them completely over a period of several months. Moreover, the growing pressure to look young and healthy among Asia population can positively impact the market. In Asia, both young and old are increasingly focusing on their beauty and facial appearances. Asia Pacific is known as famous hub/ center of cosmetic surgeries. 

Market Dynamics

The major factor responsible for the growth of the Asia Pacific dermal fillers treatment market includes increase in number of cosmetic procedures and growing influence of celebrities among young population. The public demand to undergo elective surgeries to improve their physical appearance is a huge sensation in Asian countries. Moreover, the rise in the access use of social media and robust advertising of skin treatments by global celebrities have shifted the interest of young fans to follow these treatments and look ever young like their favorite celebrities. Furthermore, growing consumer spending on health and beauty, availability of affordable skincare options and rise in the number of skincare clinics and well centers provide a lucrative growth opportunity in the Asia Pacific dermal fillers treatment market. However, side effects of dermal fillers such as redness, swelling, pain, bruising and itching restrict the growth in the Asia Pacific dermal fillers treatment market.

Report Summary

The study of the Asia Pacific Dermal Fillers Treatment Market considers various market determinants, industry value chain analysis and competitor analysis of the market. The report discusses the analysis of the trade finance industry for the period 2017-2030, where the base year is 2021 and the forecast period is 2022-2030. The report provides a detailed analysis of the Asia Pacific Dermal Fillers Treatment Market across 17 Chapters and 230 pages. The report includes data presentation across 70 tables and 122 statistical figures. 

The report provides PESTLE analysis, which is a tool to examine the external market environment factors that have an impact on the industry. The PESTLE analysis examines the Political, Economic, Social, Technological, Environmental and Legal factors in the external environment. Thus, sufficiently examining the threats and weaknesses of the industry. The research report also provides Porter’s five forces analysis wherein bargaining power of buyers is low and competitive rivalry is high. 

The subsequent section provides details of the market analysis based on different segments such as material, product, application, end user and country. The report includes detailed study of value chain of the industry. It includes raw material providers, manufacturer, service provider and end user. The report also covers extensively about the key competitors in the market for dermal fillers treatment.

Key Takeaways from the Asia Pacific Dermal Fillers Treatment Market Report

• Based on material, the hyaluronic acid segment holds the highest share in the Asia Pacific dermal fillers treatment market in 2021 owing to reduced risk of associated allergic reactions and it also helps tissues to retain water so they can stay hydrated and lubricated. Whereas the fat fillers segment is anticipated to grow at the highest CAGR during the forecast period as it last longer and restores fullness to the face.
• In terms of product, the biodegradable segment held the largest share in the Asia Pacific dermal fillers treatment market in 2021 and is also anticipated to project the highest CAGR over the forecast period.  Biodegradable dermal fillers are more preferred as it offers flexibility to patients with respect to duration and frequency of procedures. Also, benefits such as less invasiveness, minimal recovery time and lesser side effects of temporary fillers will drive the overall biodegradable dermal filler market growth.
• On the basis of application, wrinkle correction treatment segment is estimated to hold the largest market share and highest CAGR over the forecast period owing to its high demand and introduction of new products in the market.
• By end user, the specialty & dermatology clinics segment dominated the Asia Pacific dermal fillers treatment market in 2021 and is also expected to register the highest CAGR during the forecast period as most healthcare facilities perform aesthetic procedures in dermatology clinics itself. Also, rise in number of dermatology clinics and availability of extensive range of cosmetic treatment services in the clinics itself further lead to segment growth.
• Based on country, China accounted to hold the highest market share of the Asia Pacific dermal filler treatment market in 2021 due to rising disposable income and increasing awareness of the cosmetic procedures in developed and emerging economies in the region. Whereas China and India are expected to project the highest CAGR over the forecast period.

Competitive Landscape

The key players in the Asia Pacific Dermal Fillers Treatment Market are ALLERGAN (AbbVie, Inc.), Revance Therapeutics, Inc., Merz Pharma, Galderma, Sinclair Pharma, BIOPLUS CO., LTD., Bioxis pharmaceuticals, SCULPT Luxury Dermal Fillers LTD, DR. Korman, Prollenium Medical Technologies, Suneva Medical, Anika Therapeutics, Inc. and LG Chem Ltd. among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions to have a grip of emerging market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.

Segmentation Overview 

Asia Pacific Dermal Fillers Treatment Market is segmented based on material, product, application, end user and country. The industry trends in the Asia Pacific dermal fillers treatmentmarket are sub-divided into different categories in order to get a holistic view of the Asia Pacific marketplace. 

Following are the different segments of the Asia Pacific Dermal Fillers Treatment Market:

By Material segment of the Asia Pacific Dermal Fillers Treatment Market is sub-segmented into:

• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid
• PMMA (Polymethyl methacrylate)
• Collagen Fillers
• Fat Fillers
• Others

By Product segment of the Asia Pacific Dermal Fillers Treatment Market is sub-segmented into:

• Biodegradable
• Non-Biodegradable

By Application segment of the Asia Pacific Dermal Fillers Treatment Market is sub-segmented into:

• Scar Treatment
• Wrinkle Correction Treatment
• Lip Enhancement
• Restoration of Volume/ Fullness
• Preorbital Treatment
• Others

By End User segment of the Asia Pacific Dermal Fillers Treatment Market is sub-segmented into:

• Specialty & Dermatology Clinics
• Hospitals & Clinics
• Other

By Country segment of the Asia Pacific Dermal Fillers Treatment Market is sub-segmented into:

• China
• India
• Japan
• South Korea
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific